RNTECH and DNAVision Announce Co-Marketing Agreement
News Feb 01, 2006
DNAVision and RNTECH have announced that they have signed a co-marketing agreement under which the companies will jointly offer an integrated package of high quality material biological bank, gene expression and genotyping technologies.
Post-genome era discovery processes must be based upon the combination of two key components: high quality, severely selected biological material associated with diagnostic and clinical data from large scale patient cohorts and platforms including genomics, proteomics and bioinformatics platforms.
The RNTECH/DNAVision offer associates these key components, creating an opportunity for pharmaceutical and biotechnology industries to access discovery and development expertise at an unparalleled level in oncology for biomarker and drugable target discovery and development.
"We are delighted to combine our extensive biological material bank in oncology with DNAVision’s gene expression and high-throughput genotyping platforms and offer, what we believe, a unique pharmacogenomic solution to pharmaceutical, clinical, and academic partners interested by finding new biomarkers in oncology," said Michael Bia, CEO of RNTECH.
"We believe that the quality of RNTECH’s biobank with complete clinical data and patient follow-up will provide in combination with our expertise a stronger, more clinically relevant offering for the oncology marketplace," said Jean-Pol Detiffe, CEO of DNAVision.
4000-Year Old DNA Helps Track the Spread of Rice Farming in AsiaNews
Rice farming spread far and wide in ancient Southeast Asia, but how it got there has been a mystery. Now, a study of 4000-year-old DNA—a rare find in this region—suggests it came with farmers migrating from China, where rice farming originated.
Island Life: Worm-eating Mice Hold Clues to EvolutionNews
How much space does a population need to branch out and form a new species? A small island in the Philippines, and four species of mice that live on it, have helped researchers work out the answer.READ MORE
Gonorrhoea Genome Maps Out STD Across EuropeNews
The first European-wide genomic survey of gonorrhoea has mapped antibiotic resistance in this sexually transmitted disease throughout the continent. Researchers also showed that using DNA sequencing data they could accurately determine antibiotic resistance and identify incorrect laboratory test results.
Comments | 0 ADD COMMENT
Epigenetics in the nervous system: development and disease
Oct 01 - Oct 03, 2018